1![MULTI-‐TARGET
PREDICTION
Willem
Waegeman
NGDATA
Europe
Belgium
MULTI-‐TARGET
PREDICTION
Willem
Waegeman
NGDATA
Europe
Belgium](https://www.pdfsearch.io/img/39e7db729720792283b86b2ad13298f6.jpg) | Add to Reading ListSource URL: www.ngdata.comLanguage: English - Date: 2014-03-18 20:25:45
|
---|
2![ViiV Healthcare Receives EU marketing authorization for Triumeq®, a Single-pill Regimen Containing the Integrase Inhibitor “Dolutegravir” Osaka, Japan, September 4, Shionogi & Co., Ltd. (Head Office: Osaka; P ViiV Healthcare Receives EU marketing authorization for Triumeq®, a Single-pill Regimen Containing the Integrase Inhibitor “Dolutegravir” Osaka, Japan, September 4, Shionogi & Co., Ltd. (Head Office: Osaka; P](https://www.pdfsearch.io/img/c5e756c483bd9b39f54c6028d7480e61.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2015-01-27 14:49:56
|
---|
3![Shionogi-ViiV Healthcare Starts Phase III Trial for “572-Trii” Fixed-Dose Combination HIV Therapy London, UK, 3 February 2011 – Shionogi-ViiV Healthcare, LLC announced today that the first patient has entered the c Shionogi-ViiV Healthcare Starts Phase III Trial for “572-Trii” Fixed-Dose Combination HIV Therapy London, UK, 3 February 2011 – Shionogi-ViiV Healthcare, LLC announced today that the first patient has entered the c](https://www.pdfsearch.io/img/8ea00a178d62ce5c26f59ac70e16f0b7.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2014-11-03 11:26:17
|
---|
4![Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV London, United Kingdom, 11 July 2012: Shionogi-ViiV Healthcare LLC today announced that initia Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV London, United Kingdom, 11 July 2012: Shionogi-ViiV Healthcare LLC today announced that initia](https://www.pdfsearch.io/img/d89c92398af08a8b010529fbde42b9cf.jpg) | Add to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English - Date: 2014-11-03 11:26:18
|
---|
5![Microsoft Word - Analysis of ViiV-MPP License.docx Microsoft Word - Analysis of ViiV-MPP License.docx](https://www.pdfsearch.io/img/d8990a7b065b8b963752c444ec191f21.jpg) | Add to Reading ListSource URL: infojustice.orgLanguage: English - Date: 2014-04-23 15:10:38
|
---|
6![Organic chemistry / Fixed dose combination / Pharmacology / Bristol-Myers Squibb / Cyclopropanes / Fixed-dose combination / Emtricitabine/tenofovir/efavirenz / Tenofovir/emtricitabine / Abacavir / Gilead Sciences / Chemistry / Organofluorides Organic chemistry / Fixed dose combination / Pharmacology / Bristol-Myers Squibb / Cyclopropanes / Fixed-dose combination / Emtricitabine/tenofovir/efavirenz / Tenofovir/emtricitabine / Abacavir / Gilead Sciences / Chemistry / Organofluorides](/pdf-icon.png) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2015-03-16 01:05:14
|
---|
7![Public Summary Document – November 2014 PBAC Meeting 5.2 DOLUTEGRAVIR + ABACAVIR + LAMIVUDINE dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg Public Summary Document – November 2014 PBAC Meeting 5.2 DOLUTEGRAVIR + ABACAVIR + LAMIVUDINE dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg](https://www.pdfsearch.io/img/27d42a69cf8f3ba6e59f9ae5bb5d5850.jpg) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2015-03-16 01:05:14
|
---|
8![ABRIDGED* ANTIRETROVIRAL TABLE: ADULT DOSING, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL Generic Name Abbrev. (Brand Name) Dosage Forms ABRIDGED* ANTIRETROVIRAL TABLE: ADULT DOSING, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL Generic Name Abbrev. (Brand Name) Dosage Forms](https://www.pdfsearch.io/img/b86ffc7c5d932c9610accdfe6a97e1fa.jpg) | Add to Reading ListSource URL: nccc.ucsf.eduLanguage: English - Date: 2015-01-14 12:11:12
|
---|
9![3TC® Tablets lamivudine Consumer Medicine Information What is in this leaflet? Please read this leaflet carefully 3TC® Tablets lamivudine Consumer Medicine Information What is in this leaflet? Please read this leaflet carefully](https://www.pdfsearch.io/img/d8877a5bfb0097f80d551589bc4a51d7.jpg) | Add to Reading ListSource URL: gp2u.com.auLanguage: English - Date: 2013-08-31 02:43:58
|
---|
10![3TC® Oral Solution lamivudine Consumer Medicine Information What is in this leaflet? 3TC® Oral Solution lamivudine Consumer Medicine Information What is in this leaflet?](https://www.pdfsearch.io/img/ec0cf9883023ad801da844de7593f90e.jpg) | Add to Reading ListSource URL: gp2u.com.auLanguage: English - Date: 2013-08-31 02:43:58
|
---|